Class II & Class III Devices - Nocturnal

Class II & Class III Devices

Milestones That Matter: A Conversation with KC Armstrong on Reaching “First in Human”

Milestones That Matter: A Conversation with KC Armstrong on Reaching “First in Human”

Eran Livneh2025-10-29T20:11:35+00:00October 29th, 2025|Categories: Class II & Class III Devices, Lifesaving & Implantable, Milestone-based pricing, Startups|

KC Armstrong, MSEE, is Nocturnal's Founder & President. A

2024 H1 MedTech Funding: Insights and Takeaways

2024 H1 MedTech Funding: Insights and Takeaways

Eran Livneh2024-09-23T01:14:27+00:00August 6th, 2024|Categories: Class II & Class III Devices, Funding, Milestone-based pricing, Startups|

New MedTech Funding: A Light at the End of

How to avoid five costly mistakes that can sink your device startup – Part II

How to avoid five costly mistakes that can sink your device startup – Part II

Eran Livneh2024-06-11T20:19:10+00:00June 11th, 2024|Categories: Class II & Class III Devices, Funding, Milestone-based pricing, PMA, QMS, Startups|

Five Costly Mistakes that Can Sink Your Device Startup

Five costly mistakes that can sink your device startup – Part I

Five costly mistakes that can sink your device startup – Part I

Eran Livneh2024-11-01T02:04:37+00:00May 28th, 2024|Categories: Class II & Class III Devices, Funding, Milestone-based pricing, PMA, QMS, Startups|

Five Costly Mistakes that Can Sink Your Device Startup